Wegovy for Weight Loss

Breakthrough outcomes—trusted, medically guided. Discover how Wegovy supports real, sustainable results for adults seeking change.

Why consider Wegovy?

Exceptional Results

In clinical trials, participants using Wegovy achieved up to 15% average body weight reduction—the highest among approved obesity medications to date.

Science-Driven

Wegovy is powered by semaglutide, a GLP-1 analog that helps regulate appetite and improves metabolic health—reflecting the latest advances in obesity medicine.

Medical Oversight

Every prescription is guided by expert clinicians who tailor treatment, monitor progress, and ensure safe, effective results for each individual.

Lasting Lifestyle Support

Wegovy is most effective when combined with real-life coaching and behavior change—empowering you to build sustainable health habits.

What is Wegovy?

Wegovy is a prescription injectable medication indicated for adults with obesity or overweight who have at least one weight-related health risk (such as high blood pressure, type 2 diabetes, or high cholesterol). Unlike older medications, Wegovy uses semaglutide, a GLP-1 receptor agonist originally developed for diabetes, now FDA-approved in a higher dose specifically for weight management.

Taken once weekly, Wegovy works by imitating the GLP-1 hormone to target areas of the brain that regulate appetite and food intake. This process helps reduce hunger, increases feelings of fullness, and slows the emptying of your stomach after eating.

How Effective is Wegovy?

In the pivotal STEP-1 trial published in the New England Journal of Medicine, adults taking Wegovy alongside lifestyle changes lost an average of 15% of their body weight over 68 weeks—compared to about 2.4% in the placebo group. A significant number achieved at least 10% or even 20% loss. These are results not seen with older medications.

  • Average weight loss: 34 lbs (15%) for starting weight of 230 lbs
  • Rapid satiety: Appetite reduction noticeable within 2-3 weeks
  • Improvement in blood sugar and blood pressure for many patients

Wegovy is not a "quick fix," but in combination with expert care, it can be a real catalyst for a healthier, more mobile, and more confident life.

Who is a Good Candidate?

Wegovy is intended for adults who:

  • Have a BMI ≥30, or BMI ≥27 with a condition such as hypertension or dyslipidemia
  • Have struggled to lose weight with diet and exercise alone
  • Can commit to weekly injections and regular monitoring
  • Are not pregnant, breastfeeding, or with a personal/family history of medullary thyroid cancer

Suitability is always determined with a licensed healthcare provider. At Weight Loss Medications, our team delivers personal, judgment-free assessments to ensure Wegovy or alternatives are safe and appropriate.

How is Wegovy Taken?

Wegovy is self-administered as a subcutaneous injection (into the skin of your abdomen, thigh, or upper arm) once per week. The dosing schedule starts low and increases over 16 weeks to the full 2.4 mg dose, minimizing side effects.

  1. Month 1: 0.25 mg weekly
  2. Month 2: 0.5 mg weekly
  3. Month 3: 1.0 mg weekly
  4. Month 4: 1.7 mg weekly
  5. Maintenance: 2.4 mg weekly

Medical supervision ensures dose escalation is safe and appropriate. Our clinical team provides training and ongoing support, so even those new to injectables feel confident.

What are the Side Effects?

The most common side effects are gastrointestinal—nausea, vomiting, diarrhea, and constipation, especially as the dose increases. These effects typically lessen after the first few weeks. Less common (<2%) but more serious risks include pancreatitis, gallbladder issues, and potential effects on heart rate.

  • Most GI symptoms resolve within 1-2 months
  • Rare but serious: Risk of medullary thyroid cancer
  • Ongoing monitoring and open communication with your provider are essential

If any side effect is concerning or persistent, our clinicians are accessible by secure message or phone—support is never far away.

How Does Wegovy Compare to Other Options?

Wegovy stands out for its effectiveness, but it's part of a growing class of modern medications. GLP-1 receptor agonists also include Ozempic (for type 2 diabetes), and other weight loss drugs like Saxenda and Tirzepatide. Each has unique dosing, insurance coverage, and side effect profiles.

  • Wegovy: Highest average weight loss, once-weekly, approved for obesity
  • Saxenda: Similar mechanism, daily injection, moderate average weight loss
  • Tirzepatide: Newest dual-action GLP-1/GIP agent (see our Tirzepatide page for in-depth)
  • Ozempic: Same molecule as Wegovy, but FDA-approved for diabetes—not weight loss

A medical provider can help you compare these options in the context of your personal preferences, health status, and insurance coverage.

What Support Comes with a Prescription?

At Weight Loss Medications, our care doesn't end with the prescription. You receive:

  • One-on-one virtual visits with a licensed clinician
  • Regular check-ins to monitor progress, side effects, and lab results
  • Access to dietitians and health coaches
  • Private member portal for refill requests and secure messaging

Medical weight management is about partnership. Our patients tell us that having a team invested in their journey is as important as the medication itself.

Frequently Asked Questions

Wegovy by the Numbers
15%
Average weight loss
68
Weeks studied
4.5M+
Prescriptions filled
92%
Patient satisfaction
  • Wegovy is an FDA-approved prescription medication containing semaglutide, used for chronic weight management in adults with obesity or overweight plus related health conditions. It mimics a natural hormone (GLP-1) to regulate appetite, slow stomach emptying, and help you feel fuller for longer, supporting meaningful weight loss when combined with diet and activity changes.

  • Wegovy is typically prescribed for adults with a body mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related medical problem such as high blood pressure, type 2 diabetes, or high cholesterol. Eligibility is determined by a licensed healthcare provider based on your medical history and current health status.

  • In clinical studies, most adults achieved significant weight loss on Wegovy, averaging 15% weight reduction over 68 weeks when combined with guided lifestyle support. Actual outcomes vary, but many patients report improved energy, confidence, and health markers.

  • The most common side effects are nausea, diarrhea, and constipation, especially during dose increases. Serious but rare risks include pancreatitis and gallbladder problems. Wegovy must be prescribed and monitored by a healthcare professional to ensure safety.

  • Wegovy (semaglutide) offers greater average weight loss than older medications like Saxenda, and is similar in action to other GLP-1 drugs such as Ozempic, but is specifically approved for weight management. A medical provider can guide you to the right option for your needs.

Ready to Take Control with Wegovy?

Secure your consultation today—expert medical support and real results for adults seeking a breakthrough in weight management.

Start Your Assessment